معرفی
Rune Wiseth is a Professor affiliated with the Norwegian University of Science and Technology (NTNU). His research focuses on cardiovascular disease mechanisms, particularly coronary artery disease, myocardial infarction, and inflammatory pathways. He has led and contributed to multiple international clinical trials, including the PROSPECT II and ASSAIL-MI studies, investigating vulnerable plaque identification and interleukin-6 inhibition therapies.
Key contributions include advancing near-infrared spectroscopy for plaque characterization, evaluating pharmacological agents like tocilizumab, and optimizing interventional cardiology practices. He has authored over 50 peer-reviewed articles in journals such as The Lancet, Circulation, and Journal of the American College of Cardiology, with a focus on translational research bridging basic science and clinical practice.
Wiseth collaborates extensively with institutions globally, contributing to guidelines on STEMI management and perioperative cardiac risk assessment. His work integrates imaging innovations, biomarker discovery, and interventional strategies to improve cardiovascular outcomes.
